...
首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Electroacupuncture Ameliorates Acute Lung Injury through Promoting Gastrointestinal Motility in Rats with Acute Pancreatitis
【24h】

Electroacupuncture Ameliorates Acute Lung Injury through Promoting Gastrointestinal Motility in Rats with Acute Pancreatitis

机译:电针通过促进急性胰腺炎大鼠的胃肠动力来减轻急性肺损伤

获取原文

摘要

Objective. Gastrointestinal disfunction and acute lung injury (ALI) were common in acute pancreatitis (AP). The effect of electro-acupuncture (EA) on gastrointestinal motility and ALI in rats with AP was investigated to verify the theory of “lung and large intestine are interior exteriorly related” in traditional Chinese medicine.Methods. Male Sprague-Dawley rats were randomly divided into the normal group, model group, and EA group. AP model was established by three injections of 20% L-arginine at 1 h intervals. EA were applied to bilateral ST-25 and ST-36 for 30 minutes twice a day after modeling for 3 days. Arterial blood, pancreas, lung, and intestinal tissues were collected for detecting the inflammatory factors and histopathology. Intestinal propulsion rate (IPR) was also measured at 72 h.Results. EA treatment improved IPR and increased CCK-8 level compared with model group (P< 0.05). It lowered the serum levels of TNF-αand IL-6 and increased the level of IL-4 with no effect on IL-10. EA treatment reduced serum vasoactive intestinal peptide (VIP) and myeloperoxidase (MPO) level in the lung and the pathologic scores of pancreas, lung and intestine were decreased (P< 0.05).Conclusion. EA treatment could promote gastrointestinal motility through inhibiting VIP, and promoting CCK expression and regulate pro- and anti-inflammatory mediators to ameliorate ALI in AP.
机译:目的。胃肠功能紊乱和急性肺损伤(ALI)在急性胰腺炎(AP)中很常见。研究了电针(EA)对AP大鼠胃肠动力和ALI的影响,以验证中药“肺与大肠是内外相关”的理论。将雄性Sprague-Dawley大鼠随机分为正常组,模型组和EA组。通过以1 h间隔三次注射20%L-精氨酸建立AP模型。建模3天后,每天两次将EA应用于双边ST-25和ST-36,时间为30分钟。收集动脉血,胰腺,肺和肠组织以检测炎性因子和组织病理学。在72 ath时也测量了肠道推进率(IPR)。与模型组相比,电针治疗可改善IPR并增加CCK-8水平(P <0.05)。它降低了血清TNF-α和IL-6的水平,增加了IL-4的水平,而对IL-10没有影响。 EA治疗降低了肺中的血清血管活性肠肽(VIP)和髓过氧化物酶(MPO)水平,并且胰腺,肺和肠的病理学评分降低了(P <0.05)。 EA治疗可通过抑制VIP,促进CCK表达并调节促炎和抗炎介质来改善AP中的ALI,从而促进肠胃蠕动。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号